To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPA1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
521 supporting clones for gene RPA1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB448480 testis .a 1 to 425 1 to 428   tiling clone,   428/428
(100 %)
4 diff
(99.1 %id)
NM_002945.3   .a 1 to 4345 1 to 4345 exact RefSeq,   4345/4345
(100 %)
0 diff
(100 %id)
BM460385 eye, retinoblastoma .a 6 to 804 1 to 803       803/1053
(76 %)
9 diff
(99.2 %id)
BM462468 leiomyosarcoma, uterus .a 6 to 803 1 to 804       804/1013
(79 %)
8 diff
(99.3 %id)
BM557563 duodenal adenocarcinoma, cell line, small intestine .a 12 to 806 1 to 796       796/1006
(79 %)
9 diff
(99.2 %id)
BP282160 bone marrow .a 13 to 594 1 to 585       585/587
(99 %)
5 diff
(99.2 %id)
BM455112 lymph, lymphoma, cell line .a 15 to 871 1 to 870       867/1171
(74 %)
15 diff
(98.8 %id)
CR985575 T-Lymphocytes .a 20 to 619 1 to 605       603/605
(99 %)
7 diff
(98.9 %id)
BP245647 Kidney .a 22 to 602 1 to 580       580/581
(99 %)
3 diff
(99.5 %id)
BM193377 leukopheresis .a 22 to 342 1 to 323       323/327
(98 %)
10 diff
(97.0 %id)
DB454919 testis .a 30 to 517 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
AK289704 brain .a 35 to 2449 1 to 2415 exact     2415/2415
(100 %)
5 diff
(99.8 %id)
BP249625 Kidney .a 35 to 617 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA199544 brain .a 36 to 621 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BP245926 Kidney .a 38 to 624 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BU169966 embryonal carcinoma, cell line, testis .a 39 to 818 1 to 793       793/939
(84 %)
31 diff
(96.7 %id)
CN269070 embryonic stem cells, cell lines H1, H7, andH9 .a 40 to 786 1 to 747       747/747
(100 %)
1 diff
(99.9 %id)
DR157483 human embryonic stem cells differentiated toan early endodermal cell type .a 40 to 803 1 to 764       764/764
(100 %)
1 diff
(99.9 %id)
BX344785 Neuroblastoma Cot 10-normalized .a 41 to 860 1 to 819       819/819
(100 %)
2 diff
(99.8 %id)
BG333423 large cell carcinoma, lung .a 41 to 875 1 to 846       844/847
(99 %)
19 diff
(97.8 %id)
AL521526 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 43 to 968 1 to 926       926/926
(100 %)
3 diff
(99.7 %id)
BM541370 leiomyosarcoma, uterus .a 43 to 1066 1 to 1024       1024/1060
(96 %)
26 diff
(97.6 %id)
BE781778 eye, retinoblastoma .a 45 to 461 1 to 417       417/417
(100 %)
1 diff
(99.8 %id)
CN269068 embryonic stem cells, cell lines H1, H7, andH9 .a 47 to 224 1 to 180       180/180
(100 %)
2 diff
(98.9 %id)
CN269074 embryonic stem cells, cell lines H1, H7, andH9 .a 47 to 704 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
M63488   .a 47 to 2440 1 to 2393 exact tiling clone,   2393/2393
(100 %)
5 diff
(99.8 %id)
AL526685 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 48 to 1044 1 to 993       993/993
(100 %)
14 diff
(98.6 %id)
BM564923 eye, retinoblastoma .a 48 to 878 1 to 835       835/1006
(83 %)
14 diff
(98.7 %id)
BE781774 eye, retinoblastoma .a 50 to 461 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BX339968 Placenta Cot 25-normalized .a 52 to 1143 1 to 1082       1082/1086
(99 %)
24 diff
(97.8 %id)
CN269071 embryonic stem cells, DMSO-treated H9 cellline .a 54 to 846 1 to 791       791/792
(99 %)
6 diff
(99.3 %id)
BX477548   .a 55 to 621 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
CX786159 human embryonic stem cells .a 63 to 735 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
AL553255 placenta, Placenta Cot 25-normalized .a 70 to 1026 24 to 974       951/1007
(94 %)
14 diff
(98.7 %id)
CN484288 eye .a 70 to 677 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
BM451965 eye, retinoblastoma .a 72 to 926 1 to 866       866/899
(96 %)
15 diff
(98.4 %id)
AB209732 aorta endothelial cell .a 73 to 2047 1 to 1975 T351A     1975/1975
(100 %)
2 diff
(99.9 %id)
BC018126 Uterus, leiomyosarcoma .a 73 to 2866 1 to 2795 exact tiling clone, available from MGC, AAA   2795/2795
(100 %)
6 diff
(99.8 %id)
CN269072 embryonic stem cells, cell lines H1, H7, andH9 .a 73 to 668 1 to 596       596/596
(100 %)
3 diff
(99.5 %id)
CX871929 embryonic stem .a 73 to 762 1 to 690       690/690
(100 %)
0 diff
(100 %id)
DB449326 testis .a 75 to 479 1 to 407       407/407
(100 %)
4 diff
(99.1 %id)
CN269065 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 78 to 839 1 to 762       762/762
(100 %)
2 diff
(99.8 %id)
CN269062 embryonic stem cells, DMSO-treated H9 cellline .a 84 to 702 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
BE882977 leiomyosarcoma, uterus .a 91 to 461 1 to 371       371/371
(100 %)
1 diff
(99.8 %id)
BE887899 leiomyosarcoma, uterus .a 95 to 461 1 to 366       366/366
(100 %)
1 diff
(99.8 %id)
DA618164   .a 100 to 674 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BU171109 eye, retinoblastoma .a 101 to 876 1 to 778       778/824
(94 %)
4 diff
(99.6 %id)
EL733097 mixed .a 116 to 773 1 to 658       658/658
(100 %)
0 diff
(100 %id)
BU173007 eye, retinoblastoma .a 116 to 942 1 to 835       835/899
(92 %)
21 diff
(97.7 %id)
CD642567 Embryonic Stem cells .a 145 to 907 1 to 762       762/789
(96 %)
16 diff
(98.0 %id)
BE003017 breast_normal .a 154 to 471 16 to 333       318/333
(95 %)
6 diff
(98.2 %id)
AU127165   .a 155 to 805 2 to 654   capped   653/665
(98 %)
7 diff
(99.0 %id)
BP218744 caudate nucleus .a 158 to 739 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM456342 lymph, lymphoma, cell line .a 166 to 936 25 to 798       774/816
(94 %)
11 diff
(98.7 %id)
CX782080 human embryonic stem cells .a 172 to 987 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
BP284559 bone marrow .a 172 to 753 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA046777   .a 175 to 1067 2 to 889   capped   888/916
(96 %)
10 diff
(99.0 %id)
DA880838   .a 179 to 726 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BG393486 embryonal carcinoma, cell line, testis .a 201 to 481 197 to 479       283/479
(59 %)
6 diff
(98.8 %id)
DB199251 trachea .a 204 to 776 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ218906 leiomyosarcoma, uterus .a 213 to 1206 1 to 992       992/1016
(97 %)
12 diff
(98.9 %id)
DA849478 placenta .a 246 to 802 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BM838014 Ascites, stomach .a 268 to 871 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
DA704200   .a 312 to 799 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA715860   .a 325 to 877 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA171817 amygdala .a 349 to 910 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DA305226 hippocampus .a 372 to 952 2 to 582   capped   581/586
(99 %)
2 diff
(99.7 %id)
BP268070 thyroid .a 398 to 972 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
DA573689   .a 400 to 949 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA396594 thalamus .a 404 to 1001 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA476474   .a 412 to 978 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AU128580   .a 421 to 1130 2 to 710   capped   709/709
(100 %)
12 diff
(98.4 %id)
BG755233 B-cells, primary B-cells from tonsils (cell line) .a 431 to 1189 1 to 762       762/1002
(76 %)
9 diff
(99.2 %id)
DA693846   .a 437 to 1013 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AW407237 lymph .a 465 to 830 8 to 373       366/373
(98 %)
0 diff
(100 %id)
TI_154145115   .a 465 to 1063 79 to 676       598/624
(95 %)
30 diff
(95.2 %id)
AU125797   .a 472 to 1208 2 to 741   capped   740/743
(99 %)
11 diff
(98.6 %id)
DB129755 thymus .a 496 to 1066 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BF743310 breast .a 501 to 892 14 to 405       392/405
(96 %)
6 diff
(98.6 %id)
BE251299 eye, retinoblastoma .a 508 to 1175 1 to 672       588/674
(87 %)
19 diff
(97.2 %id)
CU445544 epidermis .a 543 to 1123 594 to 14     Submitted on the opposite strand 581/605
(96 %)
0 diff
(100 %id)
CU454691 epidermis .a 543 to 1113 571 to 1     Submitted on the opposite strand 571/582
(98 %)
1 diff
(99.9 %id)
CU445408 epidermis .a 575 to 1017 443 to 1     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
T05740   .a 586 to 855 1 to 272       272/272
(100 %)
4 diff
(98.6 %id)
CN269075 embryonic stem cells, cell lines H1, H7, andH9 .a 615 to 1004 1 to 390       390/390
(100 %)
0 diff
(100 %id)
W21422 lung .a 616 to 844 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
W24896 lung .a 617 to 860 1 to 245       245/354
(69 %)
1 diff
(99.8 %id)
CN269063 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 624 to 1332 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BE245676 leukopheresis .a 625 to 1036 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
BP297212   .a 633 to 1208 1 to 577       577/581
(99 %)
3 diff
(99.5 %id)
BP418040 small intestine .a 638 to 1132 1 to 495     Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
T29748 blood, white blood cells .a 646 to 876 1 to 232       232/238
(97 %)
3 diff
(98.8 %id)
DW462726 Liver .a 647 to 998 15 to 366       352/366
(96 %)
8 diff
(97.9 %id)
BQ325555 colon_ins .a 649 to 896 248 to 1       248/248
(100 %)
0 diff
(100 %id)
BQ361066 ovary .a 649 to 896 249 to 1       249/249
(100 %)
3 diff
(98.8 %id)
BI858388 breast, mammary adenocarcinoma, cell line .a 665 to 1344 1 to 681       681/681
(100 %)
1 diff
(99.9 %id)
TI_57187018   .a 665 to 1344 55 to 735       681/681
(100 %)
1 diff
(99.9 %id)
BF088904 head_neck .a 669 to 1086 423 to 1       424/429
(98 %)
15 diff
(96.6 %id)
BF088933 head_neck .a 669 to 896 228 to 1       228/234
(97 %)
1 diff
(99.6 %id)
BI093003 cervix .a 676 to 1350 1 to 681       679/784
(86 %)
14 diff
(98.3 %id)
DA686691   .a 687 to 1238 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
CB130706 Liver .a 726 to 1208 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
AW886360 ovary .a 727 to 1279 14 to 575       562/575
(97 %)
44 diff
(92.4 %id)
DA961922 Spleen .a 735 to 1285 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BF740840 bocio_tumor .a 755 to 896 142 to 1     Submitted on the opposite strand 142/142
(100 %)
0 diff
(100 %id)
DB505699 hypothalamus .a 758 to 1259 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
AL121348 melanoma (MeWo cell line) .a 764 to 1178 1 to 415       415/415
(100 %)
1 diff
(99.8 %id)
CF785978 mixed .a 766 to 1358 9 to 605       597/792
(75 %)
29 diff
(96.4 %id)
AI052509   .a 772 to 1150 443 to 65   AAA   379/409
(92 %)
0 diff
(100 %id)
DA200717 brain .a 778 to 1319 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
CF121414 CNCAP(3)T-225 cell line, Prostate .a 802 to 1363 1 to 562       562/562
(100 %)
5 diff
(99.2 %id)
TI_154180483   .a 809 to 1416 70 to 678       609/876
(69 %)
10 diff
(98.9 %id)
CX755197 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 816 to 1487 1 to 667     Submitted on the opposite strand 667/836
(79 %)
8 diff
(99.1 %id)
BM016568 breast, mammary adenocarcinoma, cell line .a 833 to 1411 73 to 649       577/649
(88 %)
15 diff
(97.7 %id)
TI_59392235   .a 833 to 1411 73 to 649       577/649
(88 %)
15 diff
(97.7 %id)
BQ222582 leiomyosarcoma, uterus .a 838 to 1760 1 to 934       934/966
(96 %)
18 diff
(98.2 %id)
BG761657 melanotic melanoma, high MDR (cell line), skin .a 843 to 1471 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
BG764082 melanotic melanoma, high MDR (cell line), skin .a 843 to 1517 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
BG765594 melanotic melanoma, high MDR (cell line), skin .a 843 to 1569 1 to 738       738/940
(78 %)
23 diff
(97.6 %id)
BF971387 adrenal cortex carcinoma, cell line, adrenal gland .a 851 to 1560 1 to 707       707/974
(72 %)
14 diff
(98.6 %id)
BM838207 Ascites, stomach .a 857 to 1416 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
AU125631   .a 868 to 1695 2 to 829   capped   828/828
(100 %)
2 diff
(99.8 %id)
BF361037 ovary .a 873 to 1358 189 to 679       491/683
(71 %)
16 diff
(97.7 %id)
AU122638 mammary gland .a 878 to 1710 2 to 834   capped   833/833
(100 %)
5 diff
(99.4 %id)
BP332201 renal proximal tubule .a 881 to 1465 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BM711058 eye, fetal eyes .a 882 to 1365 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
CD579303 brain .a 900 to 1673 1 to 774       774/977
(79 %)
24 diff
(97.6 %id)
CD580024 brain .a 900 to 1617 1 to 720       720/722
(99 %)
26 diff
(96.4 %id)
CN269077 embryonic stem cells, DMSO-treated H9 cellline .a 902 to 1549 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
AU124434   .a 902 to 1768 2 to 867   capped   866/867
(99 %)
7 diff
(99.2 %id)
DR158498 human embryonic stem cells differentiated toan early endodermal cell type .a 903 to 1727 1 to 825       825/825
(100 %)
0 diff
(100 %id)
BP302524   .a 903 to 1479 1 to 576       576/582
(98 %)
14 diff
(97.6 %id)
BF088932 head_neck .a 911 to 1067 196 to 40       157/196
(80 %)
1 diff
(99.5 %id)
BF740748 bocio_tumor .a 911 to 1192 282 to 1     Submitted on the opposite strand 282/282
(100 %)
1 diff
(99.7 %id)
BQ325554 colon_ins .a 911 to 1148 256 to 21       236/256
(92 %)
0 diff
(100 %id)
AU119564 whole embryo, mainly head .a 923 to 1798 2 to 878   capped   877/877
(100 %)
6 diff
(99.4 %id)
BG955257 colon .a 930 to 1297 86 to 461       376/461
(81 %)
7 diff
(98.5 %id)
CX873010 embryonic stem .a 941 to 1804 1 to 864       864/864
(100 %)
0 diff
(100 %id)
BM542894 embryonal carcinoma, cell line, testis .a 942 to 1775 1 to 837       837/988
(84 %)
12 diff
(98.8 %id)
BM828593 Ascites, stomach .a 942 to 1223 1 to 282       282/282
(100 %)
0 diff
(100 %id)
BG900169 cartilage .a 943 to 1271 86 to 414       329/344
(95 %)
6 diff
(98.3 %id)
BQ214159 embryonal carcinoma, cell line, testis .a 948 to 1489 1 to 548       548/894
(61 %)
8 diff
(99.2 %id)
TI_1948244597   .a 948 to 1965 1134 to 128       1007/1380
(72 %)
41 diff
(97.1 %id)
TI_1948244338   .a 950 to 1965 1137 to 128       1010/1399
(72 %)
20 diff
(98.6 %id)
BF945741 nervous_normal .a 954 to 1358 423 to 19     Submitted on the opposite strand 407/423
(96 %)
1 diff
(99.8 %id)
BP246114 Kidney .a 956 to 1535 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CF785886 mixed .a 961 to 1754 8 to 790       783/790
(99 %)
32 diff
(96.0 %id)
BU153418 large cell carcinoma, lung .a 973 to 1769 1 to 802       802/889
(90 %)
17 diff
(98.1 %id)
BM848213 myeloma .a 976 to 1541 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BM848384 myeloma .a 976 to 1508 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BF796027 lymph, lymphoma, cell line .a 992 to 1742 1 to 753       753/992
(75 %)
18 diff
(98.2 %id)
BI022437 marrow .a 1004 to 1426 425 to 3       423/425
(99 %)
2 diff
(99.6 %id)
BG828190 muscle, rhabdomyosarcoma .a 1011 to 1783 1 to 779       779/897
(86 %)
24 diff
(97.4 %id)
DA253177 caudate nucleus .a 1012 to 1580 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE897915 melanotic melanoma, skin .a 1014 to 1732 16 to 731       712/1007
(70 %)
28 diff
(97.3 %id)
BU517134 leiomyosarcoma, uterus .a 1016 to 1784 1 to 775       775/905
(85 %)
20 diff
(97.8 %id)
BF364217 nervous_normal .a 1017 to 1159 1 to 144       144/144
(100 %)
3 diff
(98.0 %id)
BE898956 adenocarcinoma cell line, ovary .a 1032 to 1700 1 to 675       673/890
(75 %)
8 diff
(99.2 %id)
CK000247 mixed .a 1033 to 1747 8 to 720       713/772
(92 %)
19 diff
(97.6 %id)
BG035161 adenocarcinoma, cell line, Liver .a 1034 to 1774 1 to 735       735/969
(75 %)
16 diff
(98.4 %id)
BE743787 adenocarcinoma cell line, ovary .a 1040 to 1774 1 to 739       739/745
(99 %)
22 diff
(97.1 %id)
CB121597 Liver .a 1049 to 1601 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
CB160550 Liver .a 1049 to 1531 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
BG036436 adenocarcinoma, cell line, Prostate .a 1050 to 1774 7 to 734       728/808
(90 %)
17 diff
(97.9 %id)
BI050905 placenta_normal .a 1062 to 1356 309 to 17       294/310
(94 %)
2 diff
(99.4 %id)
TI_1948244337   .a 1062 to 1965 1034 to 125       910/1215
(74 %)
14 diff
(98.9 %id)
TI_1948244080   .a 1064 to 1965 1029 to 129       901/1434
(62 %)
12 diff
(99.2 %id)
BE292972 adenocarcinoma cell line, colon .a 1069 to 1737 1 to 665       665/668
(99 %)
9 diff
(98.7 %id)
TI_1948244862   .a 1073 to 1965 1014 to 127       888/1335
(66 %)
8 diff
(99.5 %id)
BE086998 breast .a 1076 to 1489 423 to 9     Submitted on the opposite strand 414/423
(97 %)
3 diff
(99.3 %id)
BE932015 head_neck .a 1080 to 1541 13 to 474       462/474
(97 %)
6 diff
(98.8 %id)
BE932029 head_neck .a 1080 to 1519 13 to 452       440/452
(97 %)
6 diff
(98.7 %id)
BU184357 leiomyosarcoma, uterus .a 1099 to 1862 12 to 778       767/902
(85 %)
18 diff
(98.1 %id)
FN120943 breast carcinoma .a 1111 to 1206 101 to 5     Submitted on the opposite strand 97/101
(96 %)
0 diff
(100 %id)
BF698180 brain, primitive neuroectoderm .a 1111 to 1772 1 to 662       658/821
(80 %)
19 diff
(97.7 %id)
BG029093 Bone, osteosarcoma, cell line .a 1130 to 1624 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BF344035 brain, glioblastoma with EGFR amplification .a 1136 to 1772 1 to 641       641/939
(68 %)
19 diff
(98.0 %id)
BG120570 adenocarcinoma, cell line, Liver .a 1145 to 1764 1 to 624       624/934
(66 %)
9 diff
(99.1 %id)
AW801632 uterus .a 1147 to 1464 15 to 332       318/332
(95 %)
7 diff
(97.9 %id)
AW801696 uterus .a 1147 to 1561 31 to 445       415/445
(93 %)
7 diff
(98.5 %id)
BF983057 duodenal adenocarcinoma, cell line, small intestine .a 1147 to 1857 1 to 711       711/771
(92 %)
17 diff
(97.8 %id)
BP337961 Spleen .a 1148 to 1729 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM456944 embryonal carcinoma, cell line, testis .a 1151 to 2142 1 to 1004       1004/1045
(96 %)
20 diff
(98.1 %id)
BG119012 adenocarcinoma, cell line, Liver .a 1153 to 1867 1 to 711       711/802
(88 %)
17 diff
(97.9 %id)
BF904452 marrow .a 1180 to 1621 443 to 4     Submitted on the opposite strand 440/443
(99 %)
1 diff
(99.8 %id)
TI_154188069   .a 1180 to 2005 120 to 932       813/925
(87 %)
17 diff
(98.2 %id)
CN269066 embryonic stem cells, DMSO-treated H9 cellline .a 1181 to 1850 1 to 670       670/670
(100 %)
0 diff
(100 %id)
BE171973 head_neck .a 1188 to 1620 9 to 442       434/448
(96 %)
14 diff
(96.9 %id)
BE778072 eye, retinoblastoma .a 1208 to 1772 144 to 723       582/1105
(52 %)
37 diff
(96.7 %id)
TI_1948244596   .a 1208 to 1965 882 to 125       758/1249
(60 %)
5 diff
(99.6 %id)
TI_1948244861   .a 1208 to 1965 877 to 121       757/1267
(59 %)
15 diff
(98.9 %id)
TI_1948244079   .a 1210 to 1965 881 to 124       758/1260
(60 %)
8 diff
(99.4 %id)
BP204497 coronary artery .a 1212 to 1788 1 to 577       577/581
(99 %)
2 diff
(99.7 %id)
AA143250   .a 1228 to 1641 1 to 418       418/418
(100 %)
4 diff
(99.1 %id)
BP226898   .a 1239 to 1820 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BG826869 muscle, rhabdomyosarcoma .a 1243 to 1891 1 to 649       649/650
(99 %)
1 diff
(99.9 %id)
BQ326295 colon_normal .a 1249 to 1673 437 to 7       435/437
(99 %)
4 diff
(99.1 %id)
BE177132 head_neck .a 1252 to 1409 1 to 161       161/161
(100 %)
9 diff
(94.5 %id)
BX488619   .a 1253 to 1910 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
BM456314 lymph, lymphoma, cell line .a 1282 to 2120 1 to 846       846/858
(98 %)
14 diff
(98.4 %id)
CN269064 embryonic stem cells, DMSO-treated H9 cellline .a 1329 to 1649 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
F06727 brain, total brain .a 1365 to 1729 1 to 364       364/364
(100 %)
1 diff
(99.8 %id)
DB450494 testis .a 1378 to 1628 1 to 253       253/253
(100 %)
17 diff
(93.3 %id)
CX784116 human embryonic stem cells .a 1390 to 1968 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CN269069 embryonic stem cells, cell lines H1, H7, andH9 .a 1408 to 1985 25 to 602       578/602
(96 %)
6 diff
(99.1 %id)
AW403744 lymph .a 1487 to 1704 13 to 230       218/230
(94 %)
6 diff
(97.4 %id)
BF028723 bladder, carcinoma, cell line .a 1494 to 2167 1 to 679       677/682
(99 %)
36 diff
(94.8 %id)
AW801680 uterus .a 1495 to 1911 423 to 7       417/424
(98 %)
2 diff
(99.6 %id)
BM844440 myeloma .a 1499 to 2054 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BM847443 myeloma .a 1499 to 2028 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BM845370 myeloma .a 1499 to 1924 1 to 426       426/426
(100 %)
0 diff
(100 %id)
BM848514 myeloma .a 1499 to 1877 1 to 379       379/379
(100 %)
0 diff
(100 %id)
BG251944 adenocarcinoma, cell line, Liver .a 1525 to 2262 1 to 737       737/985
(74 %)
16 diff
(98.4 %id)
BQ222302 epithelioid carcinoma, Pancreas .a 1528 to 2371 1 to 844       844/849
(99 %)
10 diff
(98.9 %id)
BF919259 nervous_tumor .a 1530 to 2030 505 to 2     Submitted on the opposite strand 504/516
(97 %)
10 diff
(98.1 %id)
AW799691 uterus .a 1531 to 1895 7 to 373       367/373
(98 %)
12 diff
(96.8 %id)
BX425090 placenta .a 1544 to 2434 1 to 887       887/961
(92 %)
16 diff
(98.4 %id)
CR615851 placenta .a 1544 to 2855 1 to 1312   tiling clone,   1312/1312
(100 %)
0 diff
(100 %id)
BE773984 prostate_tumor .a 1549 to 1650 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
BE927446 colon .a 1550 to 2130 593 to 13       581/593
(97 %)
4 diff
(99.4 %id)
BE773949 prostate_tumor .a 1556 to 2123 1 to 566       566/566
(100 %)
8 diff
(98.6 %id)
BE773961 prostate_tumor .a 1560 to 1921 364 to 1       364/364
(100 %)
3 diff
(99.2 %id)
BE773962 prostate_tumor .a 1560 to 2125 563 to 1       563/563
(100 %)
8 diff
(98.6 %id)
BE773964 prostate_tumor .a 1560 to 2081 535 to 10       526/535
(98 %)
6 diff
(98.9 %id)
BE773977 prostate_tumor .a 1560 to 1753 194 to 1       194/194
(100 %)
0 diff
(100 %id)
BE773987 prostate_tumor .a 1560 to 1753 195 to 1       195/195
(100 %)
1 diff
(99.5 %id)
BE773995 prostate_tumor .a 1560 to 1753 195 to 1       195/195
(100 %)
1 diff
(99.5 %id)
BE773997 prostate_tumor .a 1560 to 1753 193 to 1       193/193
(100 %)
2 diff
(99.0 %id)
BF373538 prostate_tumor .a 1560 to 2007 454 to 1       452/454
(99 %)
18 diff
(96.1 %id)
BI038075 nervous_tumor .a 1562 to 1922 363 to 3       361/363
(99 %)
3 diff
(99.2 %id)
BG108961 Bone, osteosarcoma, cell line .a 1565 to 2359 1 to 791       791/797
(99 %)
13 diff
(98.4 %id)
BE927448 colon .a 1574 to 2130 581 to 24       558/581
(96 %)
1 diff
(99.9 %id)
BM743518 Ascites, stomach .a 1588 to 2169 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM742537 Ascites, stomach .a 1588 to 2184 1 to 598       598/598
(100 %)
5 diff
(99.2 %id)
BU633264 cell lines, Chondrosarcoma .a 1588 to 2351 782 to 22       761/783
(97 %)
2 diff
(99.8 %id)
BF082772 breast .a 1590 to 2124 548 to 11       538/548
(98 %)
3 diff
(99.5 %id)
CN269073 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1612 to 2309 1 to 699       695/699
(99 %)
7 diff
(99.0 %id)
BU501405 eye, normal pigmented retinal epithelium .a 1612 to 2158 1 to 556       556/1113
(49 %)
25 diff
(97.8 %id)
T79674 liver and spleen .a 1623 to 1927 1 to 309       309/491
(62 %)
7 diff
(98.6 %id)
T80951 liver and spleen .a 1624 to 1907 1 to 285       285/384
(74 %)
2 diff
(99.5 %id)
T87240 liver and spleen .a 1624 to 1935 1 to 319       319/424
(75 %)
13 diff
(97.0 %id)
BE927450 colon .a 1629 to 2123 497 to 1       495/498
(99 %)
6 diff
(98.8 %id)
BE773994 prostate_tumor .a 1632 to 1904 99 to 371       269/371
(72 %)
7 diff
(98.2 %id)
BE927436 colon .a 1633 to 2128 527 to 23       505/528
(95 %)
7 diff
(98.7 %id)
BI253949 cervical carcinoma cell line, cervix .a 1648 to 2272 1 to 625       625/627
(99 %)
4 diff
(99.4 %id)
BM790584 stomach .a 1648 to 2302 1 to 655       655/655
(100 %)
3 diff
(99.6 %id)
BM851538 stomach .a 1648 to 2178 1 to 531       531/531
(100 %)
2 diff
(99.7 %id)
CN269076 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1652 to 2268 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
FN116261 breast carcinoma .a 1667 to 1750 83 to 1     Submitted on the opposite strand 83/93
(89 %)
1 diff
(99.0 %id)
BM825910 Ascites, stomach .a 1697 to 2049 1 to 353       353/353
(100 %)
0 diff
(100 %id)
BE927447 colon .a 1725 to 2123 404 to 26       379/417
(90 %)
63 diff
(84.9 %id)
DA895130 skeletal muscle .a 1746 to 2293 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BU177749 melanotic melanoma, skin .a 1750 to 2605 1 to 861       861/861
(100 %)
6 diff
(99.4 %id)
CB115068 Liver .a 1771 to 2314 1 to 544       544/544
(100 %)
2 diff
(99.7 %id)
BF955068 nervous_normal .a 1773 to 2237 495 to 32       464/498
(93 %)
2 diff
(99.6 %id)
BG287240 bladder, transitional cell papilloma, cell line .a 1773 to 2506 7 to 737       731/745
(98 %)
15 diff
(98.0 %id)
BE178302 head_neck .a 1778 to 2439 1 to 661       661/662
(99 %)
9 diff
(98.7 %id)
H83325 melanocyte .a 1779 to 2170 1 to 392       392/392
(100 %)
6 diff
(98.5 %id)
BE178464 head_neck .a 1792 to 2432 1 to 640       640/640
(100 %)
7 diff
(99.0 %id)
AL576308 placenta, Placenta Cot 25-normalized .a 1793 to 2828 1026 to 1       1026/1041
(98 %)
20 diff
(98.1 %id)
BU508590 leiomyosarcoma, uterus .a 1793 to 2677 1 to 894       894/902
(99 %)
20 diff
(97.8 %id)
BE773978 prostate_tumor .a 1801 to 2129 337 to 8       330/337
(97 %)
0 diff
(100 %id)
BE773988 prostate_tumor .a 1803 to 2130 335 to 9       327/335
(97 %)
0 diff
(100 %id)
BE773999 prostate_tumor .a 1804 to 2124 333 to 12       322/333
(96 %)
0 diff
(100 %id)
BE773973 prostate_tumor .a 1812 to 2047 336 to 99       238/336
(70 %)
1 diff
(99.8 %id)
BM556841 duodenal adenocarcinoma, cell line, small intestine .a 1817 to 2710 1 to 899       899/950
(94 %)
13 diff
(98.7 %id)
CD694419 normal nasopharynx .a 1827 to 2236 21 to 432       412/432
(95 %)
14 diff
(96.8 %id)
BE773947 prostate_tumor .a 1834 to 1989 160 to 4       157/160
(98 %)
0 diff
(100 %id)
FN110036 breast carcinoma .a 1836 to 1912 1 to 75       75/75
(100 %)
5 diff
(93.4 %id)
BF229679 colon_est .a 1859 to 2270 9 to 417       409/430
(95 %)
8 diff
(98.2 %id)
BF760988 colon_est .a 1860 to 2270 1 to 405       405/418
(96 %)
13 diff
(96.9 %id)
W27647 eye, retina .a 1864 to 2301 478 to 39       440/531
(82 %)
0 diff
(100 %id)
AL562728 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1868 to 2831 960 to 1       960/960
(100 %)
22 diff
(97.8 %id)
BF665538 brain, primitive neuroectoderm .a 1873 to 2544 1 to 672       672/672
(100 %)
3 diff
(99.6 %id)
BF699259 brain, primitive neuroectoderm .a 1873 to 2579 1 to 710       710/928
(76 %)
31 diff
(96.7 %id)
BF839013 head_neck .a 1878 to 2283 22 to 423       402/431
(93 %)
16 diff
(96.3 %id)
AA663749 schizophrenic brain S-11 frontal lobe .a 1887 to 2331 452 to 7       446/452
(98 %)
0 diff
(100 %id)
BE764622 nervous_tumor .a 1896 to 2481 591 to 5       587/591
(99 %)
0 diff
(100 %id)
AA248274   .a 1899 to 2143 1 to 244       244/244
(100 %)
7 diff
(97.2 %id)
AW853635 colon .a 1923 to 2552 631 to 3       629/631
(99 %)
0 diff
(100 %id)
BI093417 cervix .a 1924 to 2736 1 to 818       818/820
(99 %)
10 diff
(98.8 %id)
FN127623 breast carcinoma .a 1929 to 2014 86 to 1     Submitted on the opposite strand 86/86
(100 %)
0 diff
(100 %id)
AW351657 colon .a 1937 to 2307 374 to 1       374/374
(100 %)
7 diff
(98.2 %id)
H04126 placenta .a 1937 to 2093 1 to 157       157/157
(100 %)
0 diff
(100 %id)
FN125072 breast carcinoma .a 1941 to 2017 77 to 1     Submitted on the opposite strand 77/86
(89 %)
2 diff
(97.7 %id)
CB122825 Liver .a 1946 to 2499 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
BF349236 head_neck .a 1948 to 2337 1 to 392       392/392
(100 %)
6 diff
(98.5 %id)
AL521525 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1964 to 2779 829 to 19       811/829
(97 %)
0 diff
(100 %id)
CB162082 Liver .a 1976 to 2596 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
BU928089 mixed (pool of 40 RNAs) .a 1982 to 2701 1 to 727       727/861
(84 %)
28 diff
(96.8 %id)
AW853630 colon .a 1984 to 2543 558 to 1       558/558
(100 %)
21 diff
(96.3 %id)
BU602966 mixed (pool of 40 RNAs) .a 1999 to 2815 1 to 820       820/820
(100 %)
17 diff
(98.0 %id)
BF334264 colon .a 2003 to 2543 548 to 1       548/548
(100 %)
22 diff
(96.0 %id)
TI_154127595   .a 2006 to 2860 932 to 85   AAA   848/979
(86 %)
22 diff
(97.8 %id)
AL120946 melanoma (MeWo cell line) .a 2011 to 2428 1 to 417       417/417
(100 %)
2 diff
(99.6 %id)
W05851 lung .a 2014 to 2439 1 to 421   fully sequenced,   421/421
(100 %)
8 diff
(98.1 %id)
BG256538 embryonal carcinoma, cell line, testis .a 2014 to 2770 1 to 751       751/946
(79 %)
31 diff
(96.8 %id)
C00490   .a 2041 to 2376 1 to 338       338/338
(100 %)
7 diff
(98.0 %id)
BX451780 placenta .a 2041 to 2855 1 to 814       814/814
(100 %)
8 diff
(99.1 %id)
BX451779 placenta .a 2044 to 2685 1 to 644       644/807
(79 %)
43 diff
(94.7 %id)
BX373792 Placenta Cot 25-normalized .a 2044 to 2856 815 to 1       815/855
(95 %)
18 diff
(97.9 %id)
FN152533 breast carcinoma .a 2047 to 2144 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
H56269 liver and spleen .a 2054 to 2316 1 to 262       262/262
(100 %)
8 diff
(97.0 %id)
BP432249   .a 2057 to 2482 1 to 425       425/425
(100 %)
5 diff
(98.9 %id)
CB134431 Liver .a 2060 to 2589 532 to 1     Submitted on the opposite strand 532/532
(100 %)
2 diff
(99.7 %id)
TI_149314751   .a 2068 to 2854 861 to 84   AAA   778/951
(81 %)
39 diff
(95.9 %id)
TI_149297408   .a 2071 to 2854 858 to 78   AAA   781/949
(82 %)
9 diff
(99.1 %id)
TI_154038603   .a 2073 to 2860 857 to 70   AAA   788/966
(81 %)
18 diff
(98.2 %id)
TI_159681224   .a 2073 to 2860 819 to 32   AAA   788/965
(81 %)
25 diff
(97.5 %id)
DB245890 uterus, tumor tissue .a 2075 to 2640 2 to 567   capped   566/566
(100 %)
5 diff
(99.2 %id)
TI_154060652   .a 2077 to 2854 866 to 86   AAA   781/970
(80 %)
18 diff
(98.2 %id)
BX344784 Neuroblastoma Cot 10-normalized .a 2078 to 2779 722 to 19       704/722
(97 %)
0 diff
(100 %id)
BG398414 B-cells, primary B-cells from tonsils (cell line) .a 2078 to 2853 1 to 765   AAA   765/765
(100 %)
23 diff
(97.0 %id)
AW651747   .a 2079 to 2440 1 to 362       362/362
(100 %)
4 diff
(98.9 %id)
BM982476 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2079 to 2854 792 to 19   AAA   774/777
(99 %)
8 diff
(99.0 %id)
BM706258 eye, lens .a 2079 to 2676 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
CB044687 colon, juvenile granulosa tumor .a 2081 to 2738 11 to 668       658/668
(98 %)
6 diff
(99.2 %id)
TI_154039552   .a 2082 to 2854 856 to 88   AAA   769/955
(80 %)
11 diff
(98.9 %id)
AI720743 colon .a 2095 to 2854 760 to 4       757/766
(98 %)
0 diff
(100 %id)
TI_154126468   .a 2096 to 2857 845 to 92   AAA   754/925
(81 %)
14 diff
(98.5 %id)
CA420155 Bone, Human Chondrosarcoma Cell Line .a 2102 to 2854 773 to 19   AAA   755/755
(100 %)
8 diff
(99.0 %id)
AW853573 colon .a 2104 to 2773 688 to 19       670/688
(97 %)
0 diff
(100 %id)
CA444671 lung, Metastatic Chondrosarcoma .a 2113 to 2860 768 to 19   AAA   750/750
(100 %)
6 diff
(99.2 %id)
CA417246 Chondrosarcoma Cell line .a 2113 to 2860 764 to 19   AAA   746/746
(100 %)
7 diff
(99.1 %id)
CN269067 embryonic stem cells, DMSO-treated H9 cellline .a 2114 to 2613 1 to 500       500/500
(100 %)
6 diff
(98.8 %id)
BF038129 adenocarcinoma, ovary .a 2122 to 2853 1 to 725   AAA   725/725
(100 %)
12 diff
(98.4 %id)
AW853577 colon .a 2125 to 2778 656 to 3       654/656
(99 %)
0 diff
(100 %id)
CR592316 Neuroblastoma Cot 25-normalized .a 2144 to 2838 1 to 695       695/695
(100 %)
0 diff
(100 %id)
AL523942 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2144 to 2862 1 to 719       719/719
(100 %)
13 diff
(98.2 %id)
DW444540 Liver .a 2147 to 2357 16 to 226       211/226
(93 %)
6 diff
(97.4 %id)
TI_154105355   .a 2163 to 2854 775 to 84   AAA   692/693
(99 %)
2 diff
(99.8 %id)
AI589375 adenocarcinoma, Pancreas .a 2166 to 2853 689 to 5       685/689
(99 %)
0 diff
(100 %id)
CA426189 Bone, Subchondral Bone .a 2167 to 2858 707 to 19   AAA   689/689
(100 %)
8 diff
(98.9 %id)
CA446626 Chondrosarcoma, Left Pubic Bone .a 2183 to 2854 690 to 19   AAA   672/672
(100 %)
2 diff
(99.8 %id)
AA622618 lung, lung tumor .a 2203 to 2847 638 to 1       638/638
(100 %)
21 diff
(96.8 %id)
BM705734 eye, fetal eyes .a 2208 to 2692 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
TI_153975863   .a 2208 to 2773 100 to 666       567/570
(99 %)
8 diff
(98.6 %id)
BE074977 breast .a 2216 to 2805 1 to 589       589/589
(100 %)
8 diff
(98.7 %id)
BE074983 breast .a 2225 to 2809 10 to 591       582/651
(89 %)
13 diff
(98.1 %id)
BE074978 breast .a 2226 to 2805 19 to 597       579/597
(96 %)
6 diff
(99.0 %id)
BU624443 cell lines, Enchondroma .a 2235 to 2859 643 to 19   AAA   625/625
(100 %)
7 diff
(98.9 %id)
BU622885 cell lines, Enchondroma .a 2236 to 2860 641 to 19   AAA   623/623
(100 %)
3 diff
(99.6 %id)
AA576889 colon, colon tumor RER+ .a 2239 to 2859 619 to 1       619/619
(100 %)
9 diff
(98.6 %id)
AA652978 normal prostate, Prostate .a 2242 to 2853 613 to 5       609/640
(95 %)
0 diff
(100 %id)
AA632633 thyroid .a 2246 to 2860 622 to 14   AAA   609/609
(100 %)
21 diff
(96.6 %id)
AW602746 breast .a 2247 to 2809 1 to 561       561/586
(95 %)
6 diff
(99.0 %id)
AA780625   .a 2254 to 2860 627 to 25   AAA   603/669
(90 %)
20 diff
(97.1 %id)
AW602743 breast .a 2263 to 2807 1 to 545       545/547
(99 %)
11 diff
(98.0 %id)
W80991 heart .a 2263 to 2858 1 to 600   fully sequenced,   600/600
(100 %)
19 diff
(96.9 %id)
TI_159714812   .a 2265 to 2854 667 to 79   AAA   589/990
(59 %)
7 diff
(99.3 %id)
W00664 lung .a 2266 to 2566 1 to 297   fully sequenced,   297/297
(100 %)
0 diff
(100 %id)
AA127994.
matches multiple genes
uterus .a 2281 to 2860 575 to 1     also hits gene DMXL1 575/615
(93 %)
14 diff
(97.8 %id)
BI856203 breast, mammary adenocarcinoma, cell line .a 2282 to 2862 42 to 620       579/662
(87 %)
10 diff
(98.5 %id)
TI_57186064   .a 2282 to 2862 93 to 671       579/872
(66 %)
10 diff
(98.9 %id)
AW664254 2 pooled high-grade transitional celltumors, genitourinary tract .a 2291 to 2860 570 to 1       570/570
(100 %)
7 diff
(98.8 %id)
DB362083 mammary gland .a 2294 to 2854 561 to 1       561/563
(99 %)
13 diff
(97.7 %id)
DB363247   .a 2298 to 2860 561 to 1       561/561
(100 %)
13 diff
(97.7 %id)
DB363382   .a 2299 to 2854 550 to 1       550/552
(99 %)
16 diff
(97.2 %id)
TI_157602261   .a 2309 to 2867 673 to 111       563/1031
(54 %)
0 diff
(100 %id)
BM931695 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2309 to 2866 1 to 559   AAA   559/559
(100 %)
6 diff
(99.0 %id)
DB362333   .a 2312 to 2860 541 to 1       541/543
(99 %)
20 diff
(96.4 %id)
AI632995 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2315 to 2854 541 to 4       538/541
(99 %)
0 diff
(100 %id)
AA741398 2 pooled tumors (clear cell type), Kidney .a 2320 to 2862 544 to 2       543/544
(99 %)
0 diff
(100 %id)
DB365751   .a 2320 to 2866 545 to 1       545/549
(99 %)
13 diff
(97.7 %id)
TI_149274539   .a 2320 to 2860 639 to 99   AAA   541/972
(55 %)
4 diff
(99.6 %id)
BU676196 lung, Primary Lung Epithelial Cells .a 2320 to 2860 559 to 19   AAA   541/560
(96 %)
4 diff
(99.3 %id)
AA830571 germinal center B cell .a 2327 to 2860 547 to 14   AAA   534/538
(99 %)
8 diff
(98.6 %id)
AI092182 heart .a 2327 to 2856 529 to 1       529/532
(99 %)
8 diff
(98.5 %id)
W04331 lung .a 2329 to 2707 1 to 382   fully sequenced,   382/382
(100 %)
10 diff
(97.4 %id)
BQ003011 Chondrosarcoma, Left Pelvis .a 2331 to 2860 547 to 19   AAA   529/529
(100 %)
3 diff
(99.5 %id)
AA946941 2 pooled tumors (clear cell type), Kidney .a 2336 to 2862 528 to 5       524/554
(94 %)
0 diff
(100 %id)
BE675358 B-cell, chronic lymphotic leukemia .a 2338 to 2854 522 to 6       517/525
(98 %)
0 diff
(100 %id)
AA845782 Spleen .a 2339 to 2854 520 to 5       516/520
(99 %)
0 diff
(100 %id)
DB363965   .a 2339 to 2854 514 to 1       514/528
(97 %)
7 diff
(98.7 %id)
AI831228 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2341 to 2860 535 to 15   AAA   521/521
(100 %)
8 diff
(98.5 %id)
BE674801 B-cell, chronic lymphotic leukemia .a 2341 to 2854 529 to 16   AAA   514/514
(100 %)
2 diff
(99.7 %id)
BM992318 Bone, Subchondral Bone .a 2341 to 2852 529 to 19   AAA   511/511
(100 %)
3 diff
(99.5 %id)
AI984475 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2343 to 2854 534 to 22   AAA   513/513
(100 %)
20 diff
(96.2 %id)
AW517313 cervix .a 2344 to 2854 511 to 1       511/511
(100 %)
4 diff
(99.3 %id)
DV461308 cochlea, ear .a 2344 to 2725 382 to 1     Submitted on the opposite strand 382/383
(99 %)
10 diff
(97.4 %id)
CB306262 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2344 to 2854 529 to 19   AAA   511/513
(99 %)
2 diff
(99.7 %id)
BM666146 eye, fetal eyes .a 2344 to 2860 535 to 19   AAA   517/517
(100 %)
0 diff
(100 %id)
AW513297 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2345 to 2856 517 to 5       513/517
(99 %)
0 diff
(100 %id)
CB306866 Human Lung Epithelial cells, lung .a 2345 to 2854 527 to 19   AAA   509/509
(100 %)
3 diff
(99.5 %id)
BU622282 Cell Line, Chondrosarcoma .a 2345 to 2854 528 to 19   AAA   510/510
(100 %)
2 diff
(99.7 %id)
AI936315 normal prostate, Prostate .a 2347 to 2853 515 to 10       506/520
(97 %)
0 diff
(100 %id)
BM667791 eye, lens .a 2347 to 2854 525 to 19   AAA   507/507
(100 %)
3 diff
(99.5 %id)
AI924017 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2348 to 2860 539 to 27   AAA   513/520
(98 %)
2 diff
(99.7 %id)
BE855875 brain, glioblastoma (pooled) .a 2351 to 2866 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
BF594219 brain, glioblastoma (pooled) .a 2351 to 2866 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
BQ006030 Chondrosarcoma, Left Pelvis .a 2352 to 2854 520 to 19   AAA   502/502
(100 %)
3 diff
(99.5 %id)
AI571048 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2354 to 2860 505 to 1       505/519
(97 %)
6 diff
(98.9 %id)
AI678469 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2354 to 2860 519 to 16   AAA   504/505
(99 %)
15 diff
(97.1 %id)
AW104773 ovary, tumor, 5 pooled (see description) .a 2355 to 2861 505 to 1       505/515
(98 %)
18 diff
(96.6 %id)
BM989727 lung, Metastatic Chondrosarcoma .a 2355 to 2860 523 to 19   AAA   505/508
(99 %)
3 diff
(99.5 %id)
CF619418 Pooled Chondrosarcoma Tumor cells .a 2357 to 3208 4 to 864       861/877
(98 %)
6 diff
(99.4 %id)
AI672687 thymus, pooled .a 2360 to 2853 502 to 10       493/502
(98 %)
0 diff
(100 %id)
AI141113 lung .a 2368 to 2853 487 to 1       487/491
(99 %)
4 diff
(99.2 %id)
DB514348 testis .a 2370 to 2795 1 to 426     Submitted on the opposite strand 426/426
(100 %)
19 diff
(95.6 %id)
AA765885 germinal center B cell .a 2372 to 2854 486 to 8       479/486
(98 %)
0 diff
(100 %id)
AI190250 heart .a 2375 to 2856 483 to 2       482/483
(99 %)
0 diff
(100 %id)
AI075287 B-cell, chronic lymphotic leukemia .a 2376 to 2854 481 to 4       478/481
(99 %)
0 diff
(100 %id)
BF432650 brain, glioblastoma (pooled) .a 2378 to 2860 493 to 11   AAA   483/483
(100 %)
6 diff
(98.8 %id)
BQ012523 placenta .a 2378 to 2860 501 to 19   AAA   483/483
(100 %)
1 diff
(99.8 %id)
DB576984 hypothalamus .a 2380 to 2866 1 to 487     Submitted on the opposite strand 487/488
(99 %)
6 diff
(98.8 %id)
AA076360   .a 2384 to 2854 476 to 1       476/478
(99 %)
16 diff
(96.7 %id)
AI597847 Prostate .a 2390 to 2854 465 to 1       465/465
(100 %)
3 diff
(99.4 %id)
CB115760 Liver .a 2397 to 2860 480 to 17   AAA Submitted on the opposite strand 464/464
(100 %)
1 diff
(99.8 %id)
AA676456 liver and spleen .a 2399 to 2833 435 to 1       435/435
(100 %)
24 diff
(94.5 %id)
BU171114 eye, retinoblastoma .a 2400 to 2867 1 to 468       468/559
(83 %)
4 diff
(99.3 %id)
DB520328 testis .a 2403 to 2854 1 to 452     Submitted on the opposite strand 452/456
(99 %)
4 diff
(99.2 %id)
DB357999 whole embryo, mainly head .a 2407 to 2860 454 to 1       454/454
(100 %)
3 diff
(99.4 %id)
N93793 lung .a 2409 to 2854 455 to 2       454/455
(99 %)
0 diff
(100 %id)
T79592 liver and spleen .a 2411 to 2862 467 to 3       465/540
(86 %)
0 diff
(100 %id)
DB515938 testis .a 2412 to 2854 1 to 442     Submitted on the opposite strand 442/442
(100 %)
12 diff
(97.3 %id)
AI884832 anaplastic oligodendroglioma, brain .a 2413 to 2854 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
BF740090 brain, glioblastoma (pooled) .a 2413 to 2866 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
BG056516 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 2413 to 2861 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
N70538 lung .a 2420 to 2860 441 to 1   fully sequenced,   441/441
(100 %)
7 diff
(98.5 %id)
AA143051   .a 2420 to 2856 437 to 1       437/438
(99 %)
7 diff
(98.5 %id)
AI523288 aorta .a 2423 to 2854 435 to 4       432/435
(99 %)
0 diff
(100 %id)
DB513583 testis .a 2427 to 2859 1 to 435     Submitted on the opposite strand 435/435
(100 %)
12 diff
(97.3 %id)
BF093541 testis_normal .a 2429 to 2845 1 to 417       417/417
(100 %)
7 diff
(98.4 %id)
AA535606 colon .a 2431 to 2860 431 to 1       431/431
(100 %)
9 diff
(98.0 %id)
AA807897 normal prostate, Prostate .a 2440 to 2854 415 to 1       415/415
(100 %)
6 diff
(98.6 %id)
AW071518 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 2440 to 2862 424 to 2       423/424
(99 %)
0 diff
(100 %id)
BE940308 uterus_tumor .a 2444 to 2793 352 to 6       347/352
(98 %)
0 diff
(100 %id)
BF093544 testis_normal .a 2446 to 2845 1 to 402       402/402
(100 %)
24 diff
(94.1 %id)
FN150923 breast carcinoma .a 2448 to 2504 60 to 4     Submitted on the opposite strand 57/62
(91 %)
0 diff
(100 %id)
W67691 heart .a 2455 to 2854 400 to 2       399/408
(97 %)
0 diff
(100 %id)
W68118 heart .a 2455 to 2854 1 to 400   AAA   400/400
(100 %)
2 diff
(99.5 %id)
CB121937 Liver .a 2460 to 2860 417 to 17   AAA Submitted on the opposite strand 401/401
(100 %)
0 diff
(100 %id)
BG391584 embryonal carcinoma, cell line, testis .a 2471 to 2866 1 to 395   AAA   395/395
(100 %)
3 diff
(99.3 %id)
BU753990 placenta .a 2473 to 2860 405 to 18   AAA   388/388
(100 %)
1 diff
(99.8 %id)
CB119674 Liver .a 2475 to 2849 380 to 6     Submitted on the opposite strand 375/380
(98 %)
0 diff
(100 %id)
N92965 lung .a 2478 to 2866 399 to 1       399/399
(100 %)
18 diff
(95.5 %id)
BG108992 Bone, osteosarcoma, cell line .a 2478 to 2866 1 to 387   AAA   387/387
(100 %)
5 diff
(98.8 %id)
AA177087   .a 2480 to 2860 1 to 377   AAA   377/377
(100 %)
10 diff
(97.4 %id)
AI174288 Spleen .a 2494 to 2854 360 to 1       360/360
(100 %)
4 diff
(98.9 %id)
Z39753 brain, total brain .a 2499 to 2856 359 to 1       359/359
(100 %)
5 diff
(98.7 %id)
FN059980 breast carcinoma .a 2519 to 2609 1 to 91       91/92
(98 %)
2 diff
(97.9 %id)
BG989766 head_neck .a 2521 to 2742 1 to 221       221/221
(100 %)
5 diff
(97.8 %id)
N95782 lung .a 2523 to 2867 345 to 1       345/354
(97 %)
4 diff
(98.9 %id)
AW021876 cochlea, ear .a 2528 to 2857 8 to 338       331/338
(97 %)
6 diff
(98.3 %id)
N67074 cochlea, ear .a 2531 to 2857 330 to 3       328/330
(99 %)
0 diff
(100 %id)
AI253764 Prostate .a 2533 to 2854 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
N69034 lung .a 2536 to 2860 325 to 1   fully sequenced,   325/325
(100 %)
7 diff
(97.9 %id)
AA908719 carcinoid, lung .a 2544 to 2860 315 to 1       315/315
(100 %)
8 diff
(97.5 %id)
AA627487 colon, colon tumor RER+ .a 2546 to 2855 319 to 11       309/319
(96 %)
0 diff
(100 %id)
W81093 heart .a 2549 to 2861 312 to 1   fully sequenced,   312/312
(100 %)
5 diff
(98.4 %id)
BU192387 embryonal carcinoma, cell line, testis .a 2552 to 2860 1 to 309   AAA   309/309
(100 %)
2 diff
(99.4 %id)
AA629900 lung, lung carcinoma .a 2571 to 2867 297 to 2       296/297
(99 %)
0 diff
(100 %id)
BI752138 brain .a 2572 to 2727 1 to 159       159/172
(92 %)
9 diff
(94.8 %id)
FN170394 breast carcinoma .a 2575 to 2682 1 to 108       108/108
(100 %)
5 diff
(95.4 %id)
AW075348 colon, juvenile granulosa tumor .a 2579 to 2860 301 to 12   AAA   290/290
(100 %)
11 diff
(96.3 %id)
AW009552 colon .a 2583 to 2854 274 to 3       272/274
(99 %)
0 diff
(100 %id)
AI695168 colon .a 2588 to 2861 274 to 1       274/274
(100 %)
1 diff
(99.7 %id)
AA368874 placenta .a 2591 to 2830 1 to 240       240/240
(100 %)
0 diff
(100 %id)
FN154335 breast carcinoma .a 2610 to 2711 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
T24051   .a 2611 to 2854 248 to 4       245/249
(98 %)
0 diff
(100 %id)
EC455000 Prostate .a 2629 to 2742 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
EC483678 Prostate .a 2629 to 2736 1 to 108       108/109
(99 %)
10 diff
(90.9 %id)
EC483985 Prostate .a 2629 to 2730 1 to 102       102/102
(100 %)
6 diff
(94.2 %id)
EC513453 Prostate .a 2632 to 2730 6 to 106       101/106
(95 %)
6 diff
(94.4 %id)
BF832460 head_neck .a 2655 to 2786 14 to 142       129/142
(90 %)
6 diff
(95.8 %id)
W68233 heart .a 2668 to 2860 192 to 1       192/198
(96 %)
6 diff
(97.0 %id)
N74166 lung .a 2677 to 2857 181 to 1   fully sequenced,   181/181
(100 %)
10 diff
(94.5 %id)
AA991598 breast .a 2708 to 2866 159 to 1       159/159
(100 %)
0 diff
(100 %id)
EC544207 Prostate .a 2768 to 2856 1 to 90       90/97
(92 %)
2 diff
(98.0 %id)
Z45031 brain, total brain .a 2838 to 3197 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
R56356 whole brain .a 2839 to 3309 1 to 484   tiling clone,   484/484
(100 %)
13 diff
(97.4 %id)
CB138872 Liver .a 3109 to 3705 1 to 597   tiling clone,   597/597
(100 %)
2 diff
(99.7 %id)
BX110398 liver and spleen .a 3229 to 4004 1 to 775   tiling clone,   775/778
(99 %)
4 diff
(99.5 %id)
T95933 liver and spleen .a 3229 to 3414 1 to 184       184/184
(100 %)
5 diff
(97.3 %id)
AF167994 aorta .a 3500 to 4345 1 to 870   AAA   870/870
(100 %)
6 diff
(99.4 %id)
R23039 placenta .a 3616 to 3839 1 to 228       228/233
(97 %)
8 diff
(96.6 %id)
BQ004759 Chondrosarcoma, Left Pelvis .a 3616 to 4345 748 to 19   tiling clone, AAA   730/733
(99 %)
0 diff
(100 %id)
AI091214 pooled .a 3867 to 4341 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
BQ023839 placenta .a 3876 to 4342 485 to 19   AAA   467/467
(100 %)
0 diff
(100 %id)
AI458104 pooled .a 3917 to 4341 425 to 1       425/425
(100 %)
0 diff
(100 %id)
T95839 liver and spleen .a 3931 to 4338 420 to 1       420/422
(99 %)
14 diff
(96.7 %id)
H12463 placenta .a 3999 to 4338 349 to 1       349/354
(98 %)
10 diff
(97.2 %id)
Z40763 brain, total brain .a 4065 to 4345 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AA311833   .b 1 to 452 1 to 452   tiling clone,   452/452
(100 %)
2 diff
(99.6 %id)
AW966691   .b 2 to 493 1 to 491       491/516
(95 %)
16 diff
(96.9 %id)
BM560646 eye, retinoblastoma .b 26 to 491 4 to 473       470/1143
(41 %)
17 diff
(98.6 %id)
BI546872 brain, hippocampus .b 37 to 820 2 to 791       790/846
(93 %)
17 diff
(98.0 %id)
TI_44167298   .b 37 to 820 83 to 872       790/927
(85 %)
17 diff
(98.2 %id)
BM543002 embryonal carcinoma, cell line, testis .b 42 to 491 18 to 468       451/1154
(39 %)
8 diff
(99.4 %id)
CD386482 embryonic trophoblasts, made from WA01 stemcells .b 45 to 914 16 to 889       872/889
(98 %)
8 diff
(99.2 %id)
DA448468 tongue, tumor tissue .b 47 to 584 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB159743 thymus .b 47 to 628 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BI824916 pooled brain, lung, testis .b 48 to 806 9 to 768       760/768
(98 %)
8 diff
(99.0 %id)
TI_57196021   .b 48 to 806 9 to 768       760/768
(98 %)
8 diff
(99.0 %id)
BP364363 lung .b 50 to 630 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
DN994785 brain, whole brain .b 64 to 779 2 to 719       718/719
(99 %)
18 diff
(97.5 %id)
BM559215 eye, retinoblastoma .b 82 to 1071 5 to 1003       999/1003
(99 %)
20 diff
(98.1 %id)
CD654814 Embryonic Stem cells .b 82 to 825 4 to 742       739/833
(88 %)
10 diff
(98.8 %id)
BQ051185 large cell carcinoma, lung .b 83 to 819 7 to 749       743/1122
(66 %)
35 diff
(96.9 %id)
BG721637 testis .b 87 to 824 1 to 751       751/821
(91 %)
29 diff
(96.5 %id)
DA712830   .b 91 to 646 2 to 554   capped   553/553
(100 %)
6 diff
(99.0 %id)
BF981040 duodenal adenocarcinoma, cell line, small intestine .b 104 to 497 1 to 393       393/393
(100 %)
12 diff
(97.0 %id)
TI_1948244335   .b 123 to 1092 119 to 1089   tiling clone,   971/1540
(63 %)
27 diff
(98.3 %id)
TI_1948244336   .b 123 to 1079 129 to 1084       956/1284
(74 %)
28 diff
(97.9 %id)
TI_1948244077   .b 124 to 1078 117 to 1067       951/1455
(65 %)
23 diff
(98.5 %id)
TI_1948244078   .b 124 to 889 130 to 896       767/1314
(58 %)
11 diff
(99.2 %id)
TI_1948244594   .b 125 to 1080 119 to 1068       950/1441
(65 %)
18 diff
(98.8 %id)
TI_1948244595   .b 125 to 971 131 to 978       848/1303
(65 %)
12 diff
(99.1 %id)
TI_1948244859   .b 125 to 1081 119 to 1077       959/1451
(66 %)
25 diff
(98.3 %id)
TI_1948244860   .b 125 to 819 133 to 831       697/1399
(49 %)
22 diff
(98.5 %id)
BM466852 eye, retinoblastoma .b 133 to 824 33 to 727       695/1297
(53 %)
22 diff
(98.4 %id)
CX871238 embryonic stem .b 864 to 1712 1 to 849   tiling clone,   849/849
(100 %)
0 diff
(100 %id)
AW082971 pooled .c 1 to 464 463 to 1 N9T I10* tiling clone,   463/468
(98 %)
4 diff
(99.2 %id)
DB024948 testis .d 1 to 573 2 to 574 D125G tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DA507759 brain .e 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DA954067 Spleen .f 1 to 471 2 to 474   tiling clone, capped   473/473
(100 %)
3 diff
(99.4 %id)
CX866414 embryonic stem .f 358 to 1200 1 to 842 exact tiling clone,   842/842
(100 %)
4 diff
(99.6 %id)
BE810833 amnion_normal .f 421 to 633 1 to 214       214/272
(78 %)
3 diff
(98.9 %id)
BM466291 eye, retinoblastoma .f 535 to 1438 1 to 916 exact tiling clone,   916/1054
(86 %)
26 diff
(97.6 %id)
BQ230034 embryonal carcinoma, cell line, testis .f 544 to 1122 1 to 588 E20Q     588/1116
(52 %)
24 diff
(97.9 %id)
BE927444 colon .f 552 to 997 458 to 9 T30D S31E L32S E33R L34I ...     450/458
(98 %)
2 diff
(99.6 %id)
BF664182 B-cells, primary B-cells from tonsils (cell line) .f 572 to 1220 1 to 657 S9A K24E W25V R26E P27T ...     657/657
(100 %)
18 diff
(97.3 %id)
BG685852 B-cells, primary B-cells from tonsils (cell line) .f 572 to 1252 1 to 680 exact tiling clone,   680/680
(100 %)
3 diff
(99.6 %id)
BG758555 B-cells, primary B-cells from tonsils (cell line) .f 572 to 1425 1 to 865 exact tiling clone,   865/866
(99 %)
31 diff
(96.5 %id)
BM792560 Ascites, stomach .f 579 to 1208 1 to 630 exact     630/630
(100 %)
3 diff
(99.6 %id)
BE542431 cervix .f 596 to 1362 1 to 748 T30S S31E L32S E33R L34I ...     748/873
(85 %)
35 diff
(96.0 %id)
BF751549 breast_normal .f 600 to 1146 546 to 1 exact   Submitted on the opposite strand 546/546
(100 %)
4 diff
(99.3 %id)
AA460805   .f 612 to 1136 1 to 522 exact     522/522
(100 %)
4 diff
(99.3 %id)
BG992652 head_neck .g-u 1 to 390 1 to 396 A2X W4L Q5A A20S V35F ... tiling clone,   396/396
(100 %)
62 diff
(84.4 %id)
BX476936   .g-u 13 to 712 1 to 700   tiling clone,   700/700
(100 %)
5 diff
(99.3 %id)
FN105863 breast carcinoma .g-u 374 to 477 1 to 105       105/105
(100 %)
3 diff
(97.2 %id)
DB328813 placenta Gene RPA1, variant not shown         This clone was ignored    
DA853455 placenta Gene RPA1, variant not shown       capped This clone was ignored    
EB388945 eye, optic nerve Gene RPA1, variant not shown         Suspected internal deletion, this clone was ignored    
AV734594 pheochromocytoma Gene RPA1, variant not shown         Suspected internal deletion, this clone was ignored    
CA427901 Bone, Subchondral Bone Gene RPA1, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
CB994041 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB994540 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB991661 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB993002 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB990749 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB991465 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB961756 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
CB961885 placenta, pre-eclamptic placenta Gene RPA1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI